U.S. Banks Stock News

The Morning Bull - US Market Morning Update Thursday, Apr, 16 2026 US stock futures are slightly higher this morning, with E‑mini S&P 500 contracts up about 0.1%, as investors weigh steady borrowing costs against fresh signals on inflation and growth. The 10 year US Treasury yield sits near 4.27%, which suggests markets still see the Federal Reserve keeping interest rates unchanged. As a result, mortgage rates and credit card costs may stay elevated for longer. At the same time, US import...

This article walks through the key signals behind Pilgrim's Pride at around US$33.64 so you can consider whether it is starting to look like value or still has risk priced in. The share price has seen pressure recently, with returns of 6.4% over 7 days, 8.4% over 30 days and 15.6% year to date. It is still sitting on gains of 73.7% over 3 years and 60.3% over 5 years, while the past 12 months show a 34.0% decline. Recent coverage has focused on how investors are reassessing poultry...

Federated Hermes, NYSE:FHI, has acquired an 80% interest in FCP Fund Manager. The deal marks a major expansion into U.S. real estate and alternative investments. The move reflects a wider push to grow private markets exposure alongside traditional asset management. Federated Hermes enters this transaction with its shares at $58.0, after a 59.2% return over the past year and 133.5% over the past 5 years. The company already has an established position in asset management, and this deal adds...

Recent share performance and earnings profile Novanta (NOVT) has attracted investor attention after a period of mixed share performance, with a month gain of 7.2% contrasted by a 5.1% decline over the past 3 months. At a last close of US$126.45 and a market value of about US$4.6b, the company reports annual revenue of US$980.6m and net income of US$53.8m. The reported annual revenue and net income growth rates are 6.3% and 33.9% respectively. See our latest analysis for Novanta. Recent moves...

Silence Therapeutics plc ( NASDAQ:SLN ) insiders who purchased shares in the last 12 months were richly rewarded last...

We wouldn't blame MoonLake Immunotherapeutics ( NASDAQ:MLTX ) shareholders if they were a little worried about the fact...

AerCap Holdings appointed Doug Parker as a Non Executive Director to its board, bringing in a former airline industry leader. The change follows the latest AGM, which included the retirement of Julian (Brad) Branch and the re appointment of several other directors. The moves indicate ongoing board refresh at NYSE:AER that could influence future oversight and decision making. AerCap Holdings, trading on the NYSE under ticker NYSE:AER, last closed at $147.24. The stock shows a 56.3% return...

Atkore (ATKR) is back on investors’ radar after recent share moves, with the stock up around 21% over the past month but down about 4% over the past 3 months. See our latest analysis for Atkore. That recent 20.5% 1 month share price return contrasts with a 4.5% 3 month share price decline and a 19.7% 1 year total shareholder return, suggesting momentum has picked up again after a weaker stretch. If Atkore’s rebound has your attention and you want to see what else is moving around power...

Mama's Creations (MAMA) just closed FY 2026 with fourth quarter revenue of US$54.0 million and EPS of US$0.05, capping a year where trailing 12 month revenue reached US$171.7 million and EPS came in at US$0.14. The company has seen quarterly revenue move from US$33.6 million in Q4 FY 2025 to US$54.0 million in Q4 FY 2026, alongside EPS shifting from US$0.04 to US$0.05 over the same period. This is setting up a results season in which investors are closely watching how efficiently that revenue...

If you are wondering whether Zimmer Biomet Holdings at around US$94.20 offers good value today, the key is understanding what the current price actually reflects. The stock has returned 1.3% over the last 7 days, 1.0% over the last 30 days, 4.6% year to date and shows a 1.8% decline over the last year, alongside deeper 3 year and 5 year declines of 29.9% and 42.7%. These mixed returns come as the company continues to attract attention for its position in orthopedics and related medical...

If you are wondering whether LiveRamp Holdings is priced attractively right now, the starting point is understanding what the current share price is really reflecting about the business. The stock last closed at US$27.36, with returns of 3.2% over 7 days, a 1.3% decline over 30 days, a 0.2% decline year to date, 10.0% over 1 year, 16.1% over 3 years, and a 42.1% decline over 5 years. Taken together, these figures give you a mixed picture of recent and longer term performance. Recent coverage...

Eos Energy Enterprises (NasdaqCM:EOSE) has entered a joint development agreement with TURBINE-X Energy to supply 2 GWh of energy storage capacity. The storage systems are intended to power AI focused data centers, expanding Eos's presence in the AI infrastructure energy market. This agreement aligns with Eos's growing production capacity and represents a large commercial partnership for its long duration battery technology. Eos Energy Enterprises, trading at $7.08, has seen sharp share...

Webull, listed as NasdaqCM:BULL, plans to support new regulations that remove Pattern Day Trader rules. The change would allow eligible investors to place unlimited day trades without the traditional account equity threshold. Webull expects to implement these updates promptly once the regulations take effect. Webull operates as a digital brokerage platform focused on active traders who rely heavily on intraday opportunities and frequent order execution. The planned removal of Pattern Day...

Wondering whether Oshkosh at around US$140 per share still lines up with its fundamentals, or if the recent run has already priced in most of the story. The stock shows mixed recent returns, with a 10.5% decline over 7 days and a 5.1% decline over 30 days, set against a 6.0% gain year to date and a 68.7% return over the last year. These moves are occurring as Oshkosh continues to attract attention as an established name in capital goods. Investors are weighing how its position in specialized...

If you are wondering whether Hercules Capital at around US$15.68 is offering good value right now, the key is to separate short term noise from what the underlying numbers suggest. The stock has returned 4.7% over the last week and 11.5% over the last month, against a year to date return of 16.9% and a 1 year return of 1.5%. This gives you a mixed picture before even looking at the 66.4% 3 year and 58.9% 5 year figures. Recent coverage has focused on Hercules Capital as a business...

FirstEnergy (NYSE:FE) has completed a $24 million local grid modernization project in Trumbull County, Ohio. The work upgrades distribution infrastructure serving more than 16,000 customers in the area. The project is part of FirstEnergy's broader multiyear effort to modernize its transmission and distribution network. For you as an investor, this kind of project shows how a regulated utility like FirstEnergy allocates capital into its core business of delivering electricity. Grid...

Mike Krieger, co founder of Instagram and a prominent director, has resigned from Figma’s board with immediate effect. The departure comes during a period of renewed market interest in NYSE:FIG, tied to its AI powered product suite. No specific disagreement or reason has been disclosed, raising fresh questions around governance and leadership direction. For investors watching NYSE:FIG, this board change arrives at a sensitive time. The share price is $20.34, with a value score of 2 and a...

Sysco (NYSE:SYY) has agreed to acquire Restaurant Depot, expanding its presence in the U.S. Cash and Carry foodservice channel. The deal will establish Restaurant Depot as a distinct business segment within Sysco. Management expects the acquisition to be accretive to earnings within the first two years following completion. Sysco, trading at $74.09, is already a major supplier across the U.S. foodservice market, and this move adds a new format alongside its traditional distribution model...

Wondering whether Peloton Interactive's current share price reflects its true potential or too much hope? This article walks through what the latest valuation work is really saying about the stock. After years of weak long term returns, Peloton's share price recently moved 4.7% over the last week and 25.6% over the last month. This comes even though the year to date return stands at a 20.6% decline and the 1 year return is a 13.5% decline. Recent headlines around Peloton have largely focused...

In this article, we highlight three profitable AI-powered advertising stocks - Eva Live (GOAI), DoubleVerify (DV), and Stagwell (STGW).

Ovintiv (OVV) has drawn fresh attention after recent trading left the stock at $55.04, with a value score of 6 and a market cap near US$15.5b, prompting closer scrutiny from income- and value-focused investors. See our latest analysis for Ovintiv. Recent trading has been choppy, with a 1-day share price return of 0.44% and a 7-day share price return of negative 3.06%, set against a stronger 90-day share price return of 37.77% and a 1-year total shareholder return of 70.93%. This points to...

Sezzle (NasdaqCM:SEZL) has launched its Virtual Card in Canada, powered by Marqeta. The roll out extends Sezzle’s Buy Now, Pay Later offering to a new geography and broadens where consumers can use the service. This move opens additional opportunities for participating merchants to offer installment payments at more checkout locations. For readers tracking the Buy Now, Pay Later space, this Canadian launch gives more detail on how Sezzle is building out its product set and footprint. The...

Geron (NasdaqGS:GERN) appointed Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. The appointment includes a significant stock option grant as an inducement to join the company. This senior leadership change comes as Geron advances its commercial and legal priorities. Geron, listed on NasdaqGS:GERN, focuses on developing and commercializing therapies in hematology and oncology. As drug developers move from late stage research into commercialization,...

If you are wondering whether Monster Beverage is still fairly priced at around US$74.93 a share, the key question is how that price stacks up against what the business may be worth. The stock has been relatively soft in the short term, with a 0.3% decline over 7 days, a 2.8% decline over 30 days and a 1.6% decline year to date. The 1 year return sits at 29.3%, and the 3 and 5 year returns are 42.8% and 52.9% respectively. Recent coverage has focused on Monster Beverage as one of the better...